[1] JOHNSON R C.Five facts about value-added exports and implications for macroeconomics and trade research[J].Journal of Economic Perspectives,2014(2):131.
[2] HUMMELS D,ISHII J,YI K.The nature and growth of vertical specialization in world trade[J].Journal of International Economics, 2001(1):85.
[3] KOOPMAN R,WANG Z,WEI S.How much of Chinese exports is really made in China? Assessing domestic value-added when processing trade is pervasive[R].National Bureau of Economic Research,2008.
[4] FALLY T.Production staging:Measurement and facts[D].Boulder:University of Colorado Boulder,2012.
[5] ANTRAS P,CHOR D,FALLY T,et al.Measuring the upstreamness of production and trade flows[J].American Economic Review,2012(3):421.
[6] KOOPMAN R,POWERS W,WANG Z,et al.Give credit where credit is due:Tracing value added in global production chains[R].National Bureau of Economic Research,2010.
[7] KOOPMAN R,WANG Z,WEI S.Tracing value-added and double counting in gross exports[J].American Economic Review,2014(2):478.
[8] WANG Z,WEI S,ZHU K.Quantifying international production sharing at the bilateral and sector levels[R].National Bureau of Economic Research,2013.
[9] 王岚,盛斌.全球价值链分工背景下的中美增加值贸易与双边贸易利益[J].财经研究,2014(9):99.
[10] 于津平,邓娟.垂直专业化、出口技术含量与全球价值链分工地位[J].世界经济与政治论坛,2014(2):47.
[11] 黄灿,林桂军.全球价值链分工地位的影响因素研究:基于发展中国家的视角[J].对外经济贸易大学学报,2017(2):9.
[12] 郑丹青,于津平.中国制造业增加值贸易成本测度与影响研究:基于价值链分工地位视角[J].产业经济研究,2019(2):15.
[13] 于柳荫,申成霖.创新驱动下的医药科技企业绿色价值链模型构建[J].财经问题研究,2014(S1):109.
[14] 李国平,方晓晖.基于价值链分工的跨国生物医药企业在华布局模式[J].地域研究与开发,2016(4):8.
[15] 刘光东,丁洁,武博.基于全球价值链的我国高新技术产业集群升级研究:以生物医药产业集群为例[J].软科学,2011(3):39.
[16] 王文涛,付剑峰,朱义.企业创新、价值链扩张与制造业盈利能力:以中国医药制造企业为例[J].中国工业经济,2012(4):58.
[17] JOHNSON R C,NOGUERA G.Accounting for intermediates:Production sharing and trade in value added[J].Journal of International Economics,2012(2):234.